Literature DB >> 11744819

Vascular parkinsonism: a review of the precision and frequency of the diagnosis.

Thomas Foltynie1, Roger Barker, Carol Brayne.   

Abstract

Over the past century vascular parkinsonism (VP) has been established, dismissed and recently re-established as a possible clinical entity. We review the clinical features that have been proposed to suggest the diagnosis and explore how precisely VP has been defined on the basis of clinical, as well as radiological and pathological grounds. Estimates of the frequency of this condition have been based on population-based incidence and prevalence studies and also using case series of all types or parkinsonism. We performed a systematic search for all of these published studies and present their estimates of frequency. We conclude that the wide variations in these estimates may be largely explicable by variation in case definition. When studies are limited to those with either imaging or pathological support for the diagnosis, all but one estimate that 3-6% of all cases of parkinsonism have a vascular cause. In addition, features of parkinsonism have been seen in up to 38% of lacunar stroke patients at 1 year. On the basis of this appreciably high frequency, and with consideration of the implications for clinician and scientist, we suggest that VP needs to be recognised as an important clinical diagnosis, and includes a spectrum of distinct pathophysiological entities. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11744819     DOI: 10.1159/000048607

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

Authors:  Chung-Fen Tsai; Ruey-Meei Wu; Yu-Weng Huang; Li-Ling Chen; Ping-Keung Yip; Jiann-Shing Jeng
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

2.  Association of vascular parkinsonism with impaired neuronal integrity in the striatum.

Authors:  M Ihara; H Tomimoto; K Ishizu; H Yoshida; N Sawamoto; K Hashikawa; H Fukuyama
Journal:  J Neural Transm (Vienna)       Date:  2007-01-18       Impact factor: 3.575

Review 3.  [Vascular parkinsonian syndrome].

Authors:  G Ebersbach; W Poewe
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

Review 4.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

5.  Impact of subcortical white matter lesions on dopamine transporter SPECT.

Authors:  Elisabeth Funke; Andreas Kupsch; Ralph Buchert; Winfried Brenner; Michail Plotkin
Journal:  J Neural Transm (Vienna)       Date:  2013-01-24       Impact factor: 3.575

6.  Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.

Authors:  A Machado; A J Herrera; J L Venero; M Santiago; R M de Pablos; R F Villarán; A M Espinosa-Oliva; S Argüelles; M Sarmiento; M J Delgado-Cortés; R Mauriño; J Cano
Journal:  ISRN Neurol       Date:  2011-04-17

7.  Case Report of a pathologically confirmed vascular parkinsonism with early cognitive impairment and Behavioral disturbance.

Authors:  Shouzi Zhang; Yuanyuan Wang; Lixin Liu; Li Zhang; Li Ma; Haiyan Wu; Xuelin He; Mingwei Zhu; Luning Wang; Fan Mei
Journal:  BMC Neurol       Date:  2021-01-11       Impact factor: 2.474

8.  Prevalence and incidence of Parkinson's disease and other forms of parkinsonism in a cohort of elderly individuals in Southern Brazil: protocol for a population-based study.

Authors:  Gabriela Magalhães Pereira; Nayron Medeiros Soares; Neide Maria Bruscato; Emilio Hideyuki Moriguchi; João Senger; Berenice Maria Werle; Rosa Maria Martins de Almeida; Artur Francisco Schumacher-Schuh; Carlos Roberto de Mello Rieder
Journal:  BMJ Open       Date:  2021-12-15       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.